Biological Information
Background Information:
Cytokine receptors are transmembrane proteins that transmit a signal into the cell upon ligand binding. Cytokines encompass a large and diverse family of polypeptide regulators, produced widely throughout the body by cells of diverse embryological origin. Within the immune system, macrophages and activated T lymphocytes are the major producers of the macrophage-derived cytokines IL-1a, IL-1b, IL-6 and tumor necrosis factor a (TNF-a), which bind receptors designated as the type I cytokine receptor family. IL-6 is an important mediator of inflammation, immune responses, hematopoiesis and oncogenesis.
Family:
Cell Surface (Other)
Sub Family:
Cytokine
Class:
IL-6
Accession Number:
NM_000565
Organism:
Human
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Binding
Detection Method:
Radiometry
Measured Response:
Scintillation
Testing Information
Procedure Summary:
Human U266 myeloma cells rich with interleukin IL-6 receptors are used in modified HEPES buffer pH 7.1. Cells (3 x 106)‡ are incubated with 80 pM [¹²⁵I] Interleukin-6 at least 16 hours at 4°C. Non-specific binding is estimated in the presence of 10 nM interleukin-6. Cells are centrifuged and pellets are counted to determine [¹²⁵I] Interleukin-6 specifically bound. Compounds are screened at 10 µM.
Ligand:
[¹²⁵I] IL-6
Ligand Kd (nM):
0.047
Ligand Concentration:
0.08 nM
Non Specific:
10 nM IL-6
Incubation:
960 min at 4°C
Control Inhibitor:
IL-6
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
2
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Inflammation/Allergy
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS